These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 7634498
21. Short stature and delayed puberty in gymnasts: influence of selection bias on leg length and the duration of training on trunk length. Bass S, Bradney M, Pearce G, Hendrich E, Inge K, Stuckey S, Lo SK, Seeman E. J Pediatr; 2000 Feb; 136(2):149-55. PubMed ID: 10657818 [Abstract] [Full Text] [Related]
22. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major. Moayeri H, Oloomi Z. Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604 [Abstract] [Full Text] [Related]
23. Growth, puberty and endocrine function in beta-thalassaemia major. Low LC. J Pediatr Endocrinol Metab; 1997 Oct; 10(2):175-84. PubMed ID: 9364350 [Abstract] [Full Text] [Related]
24. Growth and sexual maturation in children with thalassemia major. Yesilipek MA, Bircan I, Oygür N, Ertug H, Yegin O, Güven AG. Haematologica; 1993 Oct; 78(1):30-3. PubMed ID: 8491419 [Abstract] [Full Text] [Related]
25. SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: prevalence and growth failure in relation to mutation, sex, and degree of wrist deformity. Binder G, Renz A, Martinez A, Keselman A, Hesse V, Riedl SW, Häusler G, Fricke-Otto S, Frisch H, Heinrich JJ, Ranke MB. J Clin Endocrinol Metab; 2004 Sep; 89(9):4403-8. PubMed ID: 15356038 [Abstract] [Full Text] [Related]
26. Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets. Zivičnjak M, Schnabel D, Billing H, Staude H, Filler G, Querfeld U, Schumacher M, Pyper A, Schröder C, Brämswig J, Haffner D, Hypophosphatemic Rickets Study Group of Arbeitsgemeinschaft für Pädiatrische Endokrinologie and Gesellschaft für Pädiatrische Nephrologie. Pediatr Nephrol; 2011 Feb; 26(2):223-31. PubMed ID: 21120538 [Abstract] [Full Text] [Related]
27. The multifactorial origin of growth failure in thalassaemia. Skordis N, Kyriakou A. Pediatr Endocrinol Rev; 2011 Mar; 8 Suppl 2():271-7. PubMed ID: 21705977 [Abstract] [Full Text] [Related]
28. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF). De Sanctis V, Eleftheriou A, Malaventura C, Thalassaemia International Federation Study Group on Growth and Endocrine Complications in Thalassaemia. Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():249-55. PubMed ID: 16462705 [Abstract] [Full Text] [Related]
29. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients. Shalitin S, Carmi D, Weintrob N, Phillip M, Miskin H, Kornreich L, Zilber R, Yaniv I, Tamary H. Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898 [Abstract] [Full Text] [Related]
30. Nutritional support and growth in thalassaemia major. Fuchs GJ, Tienboon P, Khaled MA, Nimsakul S, Linpisarn S, Faruque AS, Yutrabootr Y, Dewier M, Suskind RM. Arch Dis Child; 1997 Jun; 76(6):509-12. PubMed ID: 9245848 [Abstract] [Full Text] [Related]
32. Effect of different treatment regimes on linear growth and final height in beta-thalassaemia major. De Sanctis V, Katz M, Vullo C, Bagni B, Ughi M, Wonke B. Clin Endocrinol (Oxf); 1994 Jun; 40(6):791-8. PubMed ID: 8033371 [Abstract] [Full Text] [Related]
33. [Body proportions of Danish children. Curves for sitting height ratio, subischial length and arm span]. Hertel NT, Scheike T, Juul A, Main KM, Holm K, Bach-Mortensen N, Skakkebaek NE, Müller JR. Ugeskr Laeger; 1995 Dec 04; 157(49):6876-81. PubMed ID: 7491733 [Abstract] [Full Text] [Related]
34. Reference charts of sitting height, leg length and body proportions for Chinese children aged 0-18 years. Zhang YQ, Li H. Ann Hum Biol; 2015 Dec 04; 42(3):223-30. PubMed ID: 25423594 [Abstract] [Full Text] [Related]
35. Management of puberty for optimal auxological results in beta-thalassaemia major. Caruso-Nicoletti M, De Sanctis V, Cavallo L, Raiola G, Ruggiero L, Skordis N, Wonke B, International Workshop on Management of Puberty for Optimum Auxological Results. J Pediatr Endocrinol Metab; 2001 Jul 04; 14 Suppl 2():939-44. PubMed ID: 11529399 [Abstract] [Full Text] [Related]
38. Zinc status in patients with major beta-thalassemia. Mehdizadeh M, Zamani G, Tabatabaee S. Pediatr Hematol Oncol; 2008 Jul 04; 25(1):49-54. PubMed ID: 18231954 [Abstract] [Full Text] [Related]
39. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty. Lanes R, Gunczler P. Clin Endocrinol (Oxf); 1998 Aug 04; 49(2):197-202. PubMed ID: 9828907 [Abstract] [Full Text] [Related]
40. Serum growth hormone (GH) binding protein, IGF-I and IGFBP-3 in patients with beta-thalassaemia major and the effect of GH treatment. Low LC, Postel-Vinay MC, Kwan EY, Cheung PT. Clin Endocrinol (Oxf); 1998 May 04; 48(5):641-6. PubMed ID: 9666877 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]